Cargando…

Clonal analysis of cytotoxic T cell response against human melanoma

We investigated the feasibility of generating cytotoxic T cell clones against autologous human melanoma cells using a melanoma cell line (VIP) and a spontaneously transformed autologous fibroblast line (VIP- F:T). Cytotoxic lymphocytes (CL) generated against the VIP melanoma cells in one-way mixed l...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1983
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187080/
https://www.ncbi.nlm.nih.gov/pubmed/6602860
_version_ 1782146091350753280
collection PubMed
description We investigated the feasibility of generating cytotoxic T cell clones against autologous human melanoma cells using a melanoma cell line (VIP) and a spontaneously transformed autologous fibroblast line (VIP- F:T). Cytotoxic lymphocytes (CL) generated against the VIP melanoma cells in one-way mixed lymphocyte-tumor cell interactions were expanded in interleukin 2 for 2 wk. The expanded CL were cloned in limiting dilution. Two phenotypically homogeneous clones (3:1 and E.5) were obtained bearing OKT3 phenotype. Both clones expressed cytotoxicity selectively only against the sensitizing autologous target VIP. cytotoxicity assays performed with clone E.5 against the VIP target cells in the presence of autologous unfractionated lymphocytes or serum showed no modulation of autoreactivity of clone E.5. These results indicate that analysis of cellular immune response against autologous tumor cells might be feasible using autoreactive clones generated by the currently available in vitro cloning technology.
format Text
id pubmed-2187080
institution National Center for Biotechnology Information
language English
publishDate 1983
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21870802008-04-17 Clonal analysis of cytotoxic T cell response against human melanoma J Exp Med Articles We investigated the feasibility of generating cytotoxic T cell clones against autologous human melanoma cells using a melanoma cell line (VIP) and a spontaneously transformed autologous fibroblast line (VIP- F:T). Cytotoxic lymphocytes (CL) generated against the VIP melanoma cells in one-way mixed lymphocyte-tumor cell interactions were expanded in interleukin 2 for 2 wk. The expanded CL were cloned in limiting dilution. Two phenotypically homogeneous clones (3:1 and E.5) were obtained bearing OKT3 phenotype. Both clones expressed cytotoxicity selectively only against the sensitizing autologous target VIP. cytotoxicity assays performed with clone E.5 against the VIP target cells in the presence of autologous unfractionated lymphocytes or serum showed no modulation of autoreactivity of clone E.5. These results indicate that analysis of cellular immune response against autologous tumor cells might be feasible using autoreactive clones generated by the currently available in vitro cloning technology. The Rockefeller University Press 1983-07-01 /pmc/articles/PMC2187080/ /pubmed/6602860 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Clonal analysis of cytotoxic T cell response against human melanoma
title Clonal analysis of cytotoxic T cell response against human melanoma
title_full Clonal analysis of cytotoxic T cell response against human melanoma
title_fullStr Clonal analysis of cytotoxic T cell response against human melanoma
title_full_unstemmed Clonal analysis of cytotoxic T cell response against human melanoma
title_short Clonal analysis of cytotoxic T cell response against human melanoma
title_sort clonal analysis of cytotoxic t cell response against human melanoma
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187080/
https://www.ncbi.nlm.nih.gov/pubmed/6602860